Identification of genes that confer susceptibility to insulin-dependent diabetes mellitus (IDDM) will provide: 1) important new information about the pathogenesis of the disease and 2) a means for identifying individuals who may benefit from the protective therapies that are currently under investigation. Herein, we propose a continuation of our studies aimed at identifying susceptibility genes involved in IDDM, an autoimmune disease in which the insulin-producing, pancreatic beta cells are destroyed. We have already analyzed 104 affected sibpair (ASP) families and identified 5 genomic intervals that are linked to IDDM, in addition to the long recognized IDDM1 (HLA) and IDDM2 (INS region). IDDM3 has been mapped to 15q26, IDDM4 to 11q13, IDDM5 to 6q24, IDDM7 to 2q31- q33. These intervals were also reported by other investigators. We were the first group to map IDDM8 to a 21cM genomic region on 6q25-q27. In addition, suggestive evidence of linkage has been reported for more than 10 other genomic regions. Since IDDM is genetically heterogeneous and subject to environmental influences, most of the linkages still require confirmation in additional data sets. Thus, we will exploit our unique computerized network of IDDM families to expand by 150, our well established collection of ASP families. We will then use our newly ascertained family set to confirm all putative linkage intervals. As in the past, our new families will be made available to other interested investigators worldwide under the auspices of the human biological data interchange (HBDI). Outside of the HLA complex, the evidence of linkage for IDDM8 (MLS =3.4) and its impact on disease (lambdas = 1.8) are the strongest among all susceptibility intervals identified in our data set. We therefore propose to carry out fine mapping for this linkage interval. ASP analysis in 500 families will first be used to narrow the IDDM8 interval within 3-ScM. Linkage disequilibrium analysis will then be performed using the ASP and simplex families as well as unrelated patient and control populations from diverse ethnic groups (Caucasians, Chinese and African Americans). The ultimate goal of disequilibrium analysis is to detect marker-disease association and to define the genomic region that is significantly associated with the disease. Candidate genes within a genetic interval merit special attention. Within the IDDM8 interval, 2 such loci have been identified, SOD2 and IGF2R. Our preliminary observations indicate that the linkage evidence for IDDM8 is consistent with genomic imprinting, a pattern similar to that already reported for IGF2R. Provocatively, a paternally-imprinted gene responsible for beta cell disfunction in transient neonatal diabetes mellitus has also been mapped to chromosome 6. This proposal will provide important information for the ultimate identification of IDDM genes by positional cloning techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK050220-02
Application #
2430250
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Mckeon, Catherine T
Project Start
1996-06-15
Project End
1999-05-31
Budget Start
1997-06-01
Budget End
1999-05-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Florida
Department
Pathology
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Park, Y S; She, J X; Noble, J A et al. (2001) Transracial evidence for the influence of the homologous HLA DR-DQ haplotype on transmission of HLA DR4 haplotypes to diabetic children. Tissue Antigens 57:185-91
Reimsnider, S K; Eckenrode, S E; Marron, M P et al. (2000) IL4 and IL4Ralpha genes are not linked or associated with type 1 diabetes. Pediatr Res 47:246-9
Park, Y; She, J X; Wang, C Y et al. (2000) Common susceptibility and transmission pattern of human leukocyte antigen DRB1-DQB1 haplotypes to Korean and Caucasian patients with type 1 diabetes. J Clin Endocrinol Metab 85:4538-42
Eckenrode, S; Marron, M P; Nicholls, R et al. (2000) Fine-mapping of the type 1 diabetes locus (IDDM4) on chromosome 11q and evaluation of two candidate genes (FADD and GALN) by affected sibpair and linkage-disequilibrium analyses. Hum Genet 106:14-8
Marron, M P; Zeidler, A; Raffel, L J et al. (2000) Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 49:492-9
Muir, A; Ruan, Q G; Marron, M P et al. (1999) The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes 48:219-22
She, J X; Ellis, T M; Wilson, S B et al. (1999) Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes. Proc Natl Acad Sci U S A 96:8116-9
Wang, C Y; Shi, J D; Davoodi-Semiromi, A et al. (1999) Cloning of Aire, the mouse homologue of the autoimmune regulator (AIRE) gene responsible for autoimmune polyglandular syndrome type 1 (ASP1). Genomics 55:322-6
She, J X; Marron, M P (1998) Genetic susceptibility factors in type 1 diabetes: linkage, disequilibrium and functional analyses. Curr Opin Immunol 10:682-9
Marron, M P; Raffel, L J; Garchon, H J et al. (1997) Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 6:1275-82